Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ashley N. Matthew"'
Publikováno v:
Urology Case Reports, Vol 51, Iss , Pp 102606- (2023)
Mycosis fungoides involvement of genitalia is rare. We present a 63-year-old man with history of cutaneous T cell lymphoma with large cell transformation status post multiple electron beam radiation cycles who presented with a new, enlarging penile m
Externí odkaz:
https://doaj.org/article/f0d0536cdf1547aba42b0978bab7dc3f
Autor:
Ashley N. Matthew, Jacqueto Zephyr, Desaboini Nageswara Rao, Mina Henes, Wasih Kamran, Klajdi Kosovrasti, Adam K. Hedger, Gordon J. Lockbaum, Jennifer Timm, Akbar Ali, Nese Kurt Yilmaz, Celia A. Schiffer
Publikováno v:
mBio, Vol 11, Iss 2 (2020)
ABSTRACT Hepatitis C virus (HCV) infects millions of people worldwide, causing chronic liver disease that can lead to cirrhosis, hepatocellular carcinoma, and liver transplant. In the last several years, the advent of direct-acting antivirals, includ
Externí odkaz:
https://doaj.org/article/c55fb866934b41dabb2b47c634a8609a
Autor:
Nese Kurt Yilmaz, Desaboini Nageswara Rao, Hasahn L. Conway, Mohsan Saeed, Alicia Newton, Adam K. Hedger, Jacqueto Zephyr, Ashley N. Matthew, Akbar Ali, Mina Henes, Elise T Chan, Wei Huang, Christos J. Petropoulos, Celia A. Schiffer
Publikováno v:
J Med Chem
The three pan-genotypic HCV NS3/4A protease inhibitors (PIs) currently in clinical use-grazoprevir, glecaprevir, and voxilaprevir-are quinoxaline-based P2-P4 macrocycles and thus exhibit similar resistance profiles. Using our quinoxaline-based P1-P3
Autor:
Florian Leidner, Ashley N. Matthew, Linah N. Rusere, Gordon J. Lockbaum, Mina Henes, Debra A. Ragland, Desaboini Nageswara Rao, Jacqueto Zephyr, Djade I. Soumana, Celia A. Schiffer, Janet L. Paulsen, Nese Kurt Yilmaz, Kristina L. Prachanronarong, Ellen A. Nalivaika, Shurong Hou, Jennifer Timm, Akbar Ali
Publikováno v:
Chem Rev
Drug resistance is prevalent across many diseases, rendering therapies ineffective with severe financial and health consequences. Rather than accepting resistance after the fact, proactive strategies need to be incorporated into the drug design and d
Autor:
Elise T Chan, Klajdi Kosovrasti, Ashley N Matthew, Adam K Hedger, Akbar Ali, Jennifer Timm, Nese Kurt Yilmaz, Sang V Vo, Desaboini Nageswara Rao, Celia A. Schiffer, Jacqueto Zephyr, Mina Henes
Publikováno v:
J Mol Biol
Third generation Hepatitis C virus (HCV) NS3/4A protease inhibitors (PIs), glecaprevir and voxilaprevir, are highly effective across genotypes and against many resistant variants. Unlike earlier PIs, these compounds have fluorine substitutions on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d973fa125773f817b32f09d7e5edd2b8
https://europepmc.org/articles/PMC9189784/
https://europepmc.org/articles/PMC9189784/
Autor:
Ashley N, Matthew, Lauren N, Siff
Publikováno v:
International urogynecology journal. 33(5)
Autor:
Ashley N. Matthew, Lauren N. Siff
Publikováno v:
International Urogynecology Journal. 33:1351-1352
Autor:
Ashley N. Matthew, Kristina L. Prachanronarong, Djade I. Soumana, Ayşegül Özen, Celia A. Schiffer
Publikováno v:
Crit Rev Biochem Mol Biol
Direct acting antivirals have dramatically increased the efficacy and tolerability of hepatitis C treatment, but drug resistance has emerged with some of these inhibitors, including non-structural protein 3/4A protease inhibitors (PIs). Although many
Publikováno v:
Current opinion in urology. 31(1)
Purpose of review The aim of this study was to provide an updated review of robotic-assisted kidney transplant (RAKT) with an emphasis on advantages over the open kidney transplant (OKT), utility in special populations and resources available to over
Autor:
Adam K. Hedger, Wasih Kamran, Jennifer Timm, Akbar Ali, Desaboini Nageswara Rao, Nese Kurt Yilmaz, Gordon J. Lockbaum, Celia A. Schiffer, Klajdi Kosovrasti, Ashley N. Matthew, Jacqueto Zephyr, Mina Henes
Publikováno v:
mBio, Vol 11, Iss 2 (2020)
mBio
mBio, Vol 11, Iss 2, p e00172-20 (2020)
mBio
mBio, Vol 11, Iss 2, p e00172-20 (2020)
Despite significant progress, hepatitis C virus (HCV) continues to be a major health problem with millions of people infected worldwide and thousands dying annually due to resulting complications. Recent antiviral combinations can achieve >95% cure,